Original articleVascular Dysfunction in Glycogen Storage Disease Type I
Section snippets
Methods
Patients with GSD and unrelated healthy control subjects were recruited to participate in a case-control study. No more than 1 patient with GSD was enrolled per family. These investigations were approved by the Institutional Review Board of the University of Florida and the Scientific Advisory Committee of the University of Florida General Clinical Research Center. Signed informed consent (and assent when appropriate) was obtained before commencement of the investigations.
Cases were recruited
Results
BAR and IMT were not performed in 1 patient in whom hypoglycemia developed, and RAT was not performed in 2 control subjects because the technician was absent. The major case-control comparisons appear in Table II. Mean left distal IMT was greater in the GSD I cohort than in the control group. Mean augmentation index measured by RAT was higher in the GSD cohort than in the control group. Mean brachial artery diameter was not significantly different in the GSD cohort than in the control group (
Discussion
Cardiovascular disease is the leading cause of death in the United States, and hyperlipidemia is a known risk factor. Nonetheless, patients with GSD and hyperlipidemia were believed to be exempt from the consequences of this risk. This conclusion, however, was based on limited data. We have determined, using the largest number of patients with GSD studied to date, that GSD is associated with arterial dysfunction. Both carotid IMT and RAT measurement indicate arterial dysfunction in contrast to
References (20)
- et al.
Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a
Atherosclerosis
(1994) - et al.
Increased scavenger receptor class B type 1-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients
Mol Genet Metab
(2006) - et al.
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia
Free Radic Biol Med
(2002) - et al.
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis
Vasc Pharmacol
(2002) - et al.
Noninvasive tests of vascular function and structure: why and how to perform them
Am Heart J
(2001) - et al.
The paradoxical relationship between serum uric acid and cardiovascular disease
Clin Chim Acta
(2008) - et al.
Changes in coagulability of the blood during various phases of ischaemic heart-disease
Lancet
(1959) - et al.
Cellular cholesterol efflux
Biochem Biophys Acta
(2001) - et al.
High density lipoprotein as a protective factor against coronary heart diseaseThe Framingham Study
Am J Med
(1977) - et al.
Glycogen storage diseases
Rev Endocr Metab Disord
(2003)
Cited by (0)
Support for this project was provided by the Association for Glycogen Storage Disease, Scott Miller Glycogen Storage Disease Research Fund, the National Center for Research Resources General Clinical Research Center grant M01 RR 00082, National Institutes of Health, and NIH Mentored Career Award K23 RR 017560 (DAW). The authors declare no conflicts of interest.